# Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma

> **NCT06115408** · PHASE2,PHASE3 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 40 (actual)

## Conditions studied

- Uterine Leiomyoma

## Interventions

- **DRUG:** Dienogest 2 MG
- **DRUG:** N-acetyl cysteine

## Key facts

- **NCT ID:** NCT06115408
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-01
- **Primary completion:** 2024-08-31
- **Final completion:** 2024-08-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06115408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06115408, "Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06115408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*